Low-Dose Intravenous Ketamine for Adolescents With Depression and Suicidal Ideation in the Emergency Department

This early Phase I interventional trial (n=30) aims to investigate the effectiveness of a single low-dose intravenous ketamine administered in the emergency department for adolescents with treatment-resistant depression (TRD) and suicidal ideation (SI).

Conducted by Rady Children’s Hospital in San Diego, California, the study involves adolescents aged 12 to 18 who require inpatient psychiatric admission and have treatment-resistant depression. Participants will be randomly assigned to receive either ketamine or a placebo.

The primary outcome measure is the change in the Beck Depression Inventory Depression sub-scale score, assessed at multiple time points over 7 days post-treatment. Secondary outcome measures include changes in anxiety and self-concept sub-scale scores, as well as suicidal ideation scores.

The study aims to provide insights into the potential benefits of low-dose ketamine in managing depression and suicidal thoughts in adolescents presenting to the emergency department.

Topic Treatment-Resistant Depression Suicidality Depression
Compound Placebo Ketamine
Country United States of America
Visit trial

Trial Details



Trial Number

Data attribution

A large set of the trials in our database are sourced from ClinicalTrials.gov (CTG). We have modified these post to display the information in a more clear format or to correct spelling mistakes. Our database in actively updated and may show a different status (e.g. completed) if we have knowledge of this update (e.g. a published paper on the study) which isn't reflected yet on CTG. If a trial is not sourced from CTG, this is indicated on this page and you can follow the link to the alternative source of information.